1. Introduction {#sec1}
===============

Many neurological and psychiatric disorders are associated with disrupted functional connectivity between important neurocognitive networks, providing insights into the aberrant brain organization inherent to these disorders. Large-scale network analysis exploring brain function across healthy adults and brain-disordered individuals has lead to a conceptual framework referred to as the triple network model of pathology. This model highlights three distributed neurocognitive networks which are critical to maintaining effective neural communication and are found to be disrupted across many neuropsychiatric disorders ([@bb0036]): the default-mode network (DMN), the salience network (SN), and the central executive network (CEN) ([@bb0019]; [@bb0037]; [@bb0045]). Typically, the SN and CEN increase activation in response to external stimuli ([@bb0013]), whereas DMN activity is suppressed, resulting in anti-correlated coupling between the CEN and DMN ([@bb0016]; [@bb0019]; [@bb0041]). Interestingly, these same patterns of interaction among the three core neurocognitive networks are also observable in resting state fMRI data ([@bb0036]; [@bb0049]). Previous fMRI work demonstrates that resting brain organization is highly related to how the brain functions during external tasks ([@bb0016]; [@bb0054]), suggesting that studying resting brain connectivity patterns will provide useful insight into neurobiology of disordered populations ([@bb0015]; [@bb0042]; [@bb0047]) including those with Parkinson\'s disease (PD).

In addition to the fact that interactions between these three core cognitive networks are disrupted across neuropsychiatric disorders, striatal dysfunction associated with PD ([@bb0043]) may influence these network interactions. Through reciprocal connections, striatal neurons are thought to coordinate activity in many cortical regions ([@bb0033]), emphasizing the idea that PD pathology impacts widespread cortical regions as well as the basal ganglia. A recent resting state study in young adults found that the striatum interacts with regions comprising the DMN and SN ([@bb0010]). The striatum also is functionally and structurally connected with cortical areas that comprise the CEN through reciprocal circuitry with the dorsolateral prefrontal cortex and posterior parietal cortex ([@bb001]; [@bb0024]; [@bb0029]), which display abnormal activations in PD during cognitively demanding tasks ([@bb006]; [@bb0014]; [@bb0030]; [@bb0044]; [@bb0052]). Decreased functional connectivity within the DMN has been observed in PD during the resting state ([@bb0051]) and during cognitively demanding tasks ([@bb0055]), suggesting that disease-related network disruptions may influence the functional coupling between DMN--CEN interactions leading to heightened activation and dysfunctional connectivity of the DMN in PD. However, it remains to be elucidated if PD is associated with specific disruptions in functional coupling between the SN, CEN, and DMN.

Structurally, striatal neurons are highly interconnected with neurons in the insular cortex ([@bb007]; [@bb0018]), an important node of the SN. Further, dopamine depletion is thought to occur in parallel in the striatum and the insula ([@bb009]; [@bb0038]; [@bb0046]). It has been hypothesized that the loss of D2 signaling in the insula disrupts the modulation of SN activity, impairing its function in coordinating interactions between other brain networks ([@bb0037]). Altered cortico-striatal--thalamocortical neurocircuitry resulting from dysfunctional striatal dopaminergic function, as is observed in PD, is thought to lead to aberrant assignment of salience ([@bb0024]; [@bb0038]; [@bb0046]), further emphasizing the association between the striatum and salience network in PD. As striatal dysfunction is characteristic of PD and worsens with disease severity, functional coupling between the striatum and the SN is also likely to be disrupted as a function of disease progression.

In the present study, we used resting state functional magnetic resonance imaging (rs-fMRI) to identify SN--DMN, SN--CEN and CEN--DMN interactions in a group of non-demented individuals with PD and age-matched healthy participants (MC). As disease severity in PD is correlated with increased striatal disruption ([@bb0032]; [@bb0043]), we also sought to determine whether disease severity was related to functional coupling between the striatum and the SN. We hypothesized that MC participants would demonstrate negative DMN coupling with SN and CEN, and positive SN coupling with CEN, consistent with the observed patterns in young neurologically normal adults ([@bb0016]; [@bb0049]). In contrast, we expected dysfunctional SN coupling with the DMN and CEN in PD participants compared to MC. We also predicted that within the group of PD individuals, increased disease severity would be related to reduced SN--striatum functional coupling.

2. Methods {#sec2}
==========

2.1. Participants {#sec2.1}
-----------------

Twenty-six individuals diagnosed with PD and 24 healthy MC adults were enrolled. Two individuals with PD and 4 MC participants were excluded on the basis of excess motion (greater than 2 mm displacement) in the magnetic resonance imaging (MRI) scanner, resulting in a total of 24 PD (12 female, mean age 62.5 years, 2 left-handed) and 20 MC (11 female, mean age 65.9 years, 2 left-handed) participants ([Table 1](#t0005){ref-type="table"}). All participants provided informed consent in a manner approved by the institutional review boards of Boston University and Partners Human Research Committee. All participants were screened for other neurological and psychiatric illness via self-report questionnaires and physician record confirmation.

Participants diagnosed with idiopathic PD were recruited from the Parkinson\'s Disease Center at Boston Medical Center. All participants taking anti-parkinsonian medications were scanned at peak "ON" levels of medication, approximately 60--90 min after the optimized daily dose was taken. All of the participants with PD were on a combination of levodopa--carbidopa, dopamine receptor agonists, or monoamine oxidase B inhibitors. Three were also on antidepressant medication, and two of those three were also taking anti-anxiety medication as needed. All participants completed self-report mood inventories including the Beck Depression Inventory (BDI-II) and the Beck Anxiety Inventory (BAI); control participants reported minimal symptoms of anxiety and depression while PD participants reported very mild levels of anxiety and depression ([Table 1](#t0005){ref-type="table"}). While there are statistical differences between PD and MC groups on anxiety and depression scores, all participants were well below clinically significant levels of anxiety and depression disorder. No participant reported major mood or behavioral disturbance. Levodopa equivalent dosage (LED) was calculated as per recent convention ([@bb0053]) to be 368.9 mg/day on average in the PD group. All PD participants met the clinical criteria for mild to moderate disease staging (Hoehn and Yahr stages I-III) as assessed by the Unified Parkinson\'s Disease Rating Scale (UPDRS) ([@bb0035]). The median Hoehn and Yahr staging was 2, ranging from 1 (unilateral) to 3 (moderate bilateral). Out of 24 participants with Parkinson\'s disease, 3 patients were classified as Hoehn and Yahr stage 1, 4 participants as stage 1.5, 12 participants as stage 2, 3 participants as stage 2.5, and 2 participants as stage 3. Twelve participants identified tremor as being their initial symptom, 7 participants identified rigidity, and 5 participants identified difficulty with gait or balance. Average total score on the UPDRS was 27.1 and average motor subscore was 16.1 ([Table 1](#t0005){ref-type="table"}). Average disease duration of the PD group overall was 5.6 years. The average disease duration of PD individuals whose initial symptom was tremor was 5.9 years and for those whose initial symptom was akinetic/rigid was 5.3 years, which was not significantly different (*p* \> 0.5). Of the 24 PD participants, 13 were classified as right-onset (RPD) and 11 were classified as left-onset (LPD). Average disease duration of LPD participants was 4.5 years, and average disease duration of RPD participants was 6.5 years, which was not statistically different (*p* \> 0.2).

All participants were screened for contraindications to MRI. At study entry, the modified Mini-Mental State Examination (MMSE) was administered to screen for mental status. These scores were converted to standard MMSE scores on a scale of 30; all participants were classified as non-demented, averaging 28 points out of 30 ([Table 1](#t0005){ref-type="table"}). Although the MMSE score by itself is not sufficient to rule out any cognitive impairment, the objective of this cognitive screen was to ensure that all participants were above the generally accepted criteria for dementia, which is below 24 points out of 30 ([@bb0011]). All participants received detailed health history screening and a neuro-ophthalmological examination to ensure eye integrity and rule out ocular disease or abnormality. A normal anatomical brain without any evidence of gross abnormalities (i.e. infarct, tumor) was necessary for study inclusion. Other exclusionary criteria included coexisting, chronic medical illnesses, use of psychoactive medication besides antidepressants and anxiolytics in the MC group (allowed in PD), history of intracranial surgery or head trauma resulting in a loss of consciousness, and history of drug and alcohol abuse.

2.2. Neuroimaging procedure {#sec2.2}
---------------------------

Each scanning session included 20 min of structural imaging sequences followed by resting state data acquisition lasting 6 min and 35 s, during which the participants were asked to remain still and maintain eyes-open fixation on a projected image of a white cross on a black background. All scanning was performed using a 12-channel head coil in a Siemens Trio 3 T scanner (Siemens Medical Systems, Erlangen, Germany) at the Athinoula A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital. *T*~1~-weighted Magnetization Prepared-Rapid Acquisition Gradient Echo (MP-RAGE) structural scans were acquired using generalized auto-calibrating partially parallel acquisition (GRAPPA): repetition time = 2530 ms, echo time = 3.44 ms, inversion time = 1100 ms, flip angle = 7 degrees, field of view = 256 mm, slice thickness = 1 mm, 176 sagittal slices (right to left). The functional blood oxygen level dependent (BOLD) resting state fMRI data were acquired using a *T*~2~\*-weighted gradient-echo echo-planar imaging (EPI) sequence: TR = 5000 ms, TE = 30 ms, FA = 90 degrees, FOV = 256 mm, in-plane resolution 4 × 4 mm^2^. Fifty-five axial (anterior to posterior) slices with a thickness of 2 mm were acquired, oriented parallel to the anterior--posterior commissural line 76 whole-brain acquisitions were collected, and the first 5 acquisitions were subsequently discarded during image processing as "dummy" TRs for *T*~1~ stabilization, resulting in 71 acquisitions being analyzed.

2.3. Image processing {#sec2.3}
---------------------

Data pre-processing included: motion correction with MCFLIRT ([@bb0021]), brain extraction using BET ([@bb0048]), spatial smoothing with a Gaussian kernel of full-width half-maximum 6 mm, and high-pass temporal filter with Gaussian-weighted least-squares straight-line fitting with σ = 100 s. Registration of the functional EPI volumes to each individual subject\'s high-resolution MPRAGE image and registration of MPRAGE to the MNI 152 2 mm^3^ standard space template (Montreal Neurological Institute, Montreal, QC, Canada) were both accomplished using FLIRT. Four-dimensional time series data for all participants were transformed into standard space at 2 mm isotropic resolution using the registration transformation matrices.

2.4. ICA-based denoising {#sec2.4}
------------------------

After ensuring no group differences in motion during scanning (*p* \> 0.7, MC absolute mean displacement was 0.33 ± 0.19 mm; PD absolute mean displacement was 0.35 ± 0.19 mm), we conducted an ICA-based denoising approach to remove independent components within each individual subject\'s data that represented noise, including motion and scanner artifact. Independent components analysis (ICA) at the single subject level was conducted using the FSL program MELODIC ([@bb0022]; [@bb0034]). For every participant, all components were visually inspected ([@bb0023]), and all identified sources of noise were removed using FSL\'s *fsl_regfilt* utility.

2.5. Inter-network functional coupling {#sec2.5}
--------------------------------------

The default mode (DMN), central executive (CEN), and salience networks (SN) were defined using a previously published set of templates from the BrainMap Database ([Fig. 1](#f0005){ref-type="fig"}) ([@bb0017]; [@bb0028]; [@bb0027]). FSL\'s dual regression approach was used to calculate the subject specific orthogonal timecourses and spatial maps for each network of interest ([@bb9000; @bb9005; @bb9100; @bb8000; @bb7000]). Subject-specific timecourses were extracted from the SN, DMN, R- and L-CEN. The CEN in this study was defined as right- and left-hemisphere localized networks, as it was in the BrainMap database template ([Fig. 1](#f0005){ref-type="fig"}). Correlation coefficients (Pearson\'s *r*) were computed between the SN and DMN, the SN and CEN (both right and left hemispheres), and between the CEN (both right and left hemispheres) and DMN. Pearson\'s *r* coefficients were computed for each individual in first level analysis, and later used for second-level group comparison analysis. Though some of these networks include overlapping brain regions (i.e. posterior parietal lobe), this dual regression approach identifies orthogonal timecourses that are used in subsequent analysis. Independent samples *t-tests* were conducted to compare MC and PD participants on coupling values between the SN and DMN, the SN and CEN, and between the DMN and CEN. To investigate if PD disease duration or dopamine replacement medication were related to these inter-network functional coupling measures, correlation coefficients (Pearson\'s *r*) were computed between disease duration (number of years), levodopa equivalent dosage, and the functional coupling values described above.

2.6. Striatal--salience network interactions {#sec2.6}
--------------------------------------------

FreeSurfer automated structural parcellations were used to define each individual\'s entire putamen and caudate volume labels, which were combined to create a "striatum" region of interest (ROI) specific to each individual. It should be noted that while the ventral components of the caudate and putamen were included in our striatal ROI, the nucleus accumbens was not. Thus, our striatal ROI focuses on the dorsal striatum. Timecourses from each participant\'s striatal ROI were extracted and correlated with the salience network timecourse. To determine the relationship between striatal coupling with the salience network and PD symptom severity, we correlated this coupling measure with the UPDRS total score.

2.7. Volumetric analysis {#sec2.7}
------------------------

To ensure that volumetric differences between MC and PD participants were not impacting our results, the following analyses were conducted. MP-RAGE images were processed using FreeSurfer (version 5.3.0) ([[http://surfer.nmr.mgh.harvard.edu]{.ul}](http://surfer.nmr.mgh.harvard.edu){#interref1}). Standard preprocessing of structural volumes produced reconstructions that were used to determine if there were any areas of cortical thinning or subcortical atrophy in the PD group compared to MC using the QDEC utility. We also compared striatal volume between MC and PD groups to determine if there were any volumetric differences in the seed region.

3. Results {#sec3}
==========

3.1. No group differences in age, education, male-to-female ratio, mental status, cortical thinning or brain volume {#sec3.1}
-------------------------------------------------------------------------------------------------------------------

MC and PD participants were matched on age (*p* \> 0.2), education (*p* \> 0.1), male-to-female ratio (χ^2^ = 0.11, *p* \> 0.7), and MMSE scores (*p* \> 0.5, range 25.7--29.7). There were no between-group differences in whole brain cortical thinning or subcortical atrophy (*p* \> 0.05, Bonferroni corrected), and no group differences in striatal volume after controlling for intracranial volume (*p* \> 0.4).

3.2. Inter-network functional coupling disrupted in PD {#sec3.2}
------------------------------------------------------

We observed significant group differences in functional coupling between the SN and R-CEN (*t* = 2.4, *p* = 0.02, [Fig. 2](#f0010){ref-type="fig"}a), and between the DMN and R-CEN (*t* = --2.1, *p* = 0.04, [Fig. 2b](#f0010){ref-type="fig"}). Specifically, SN coupling with R-CEN was significantly more positive in MC compared to PD. In examining inter-network coupling of DMN with R-CEN, MC demonstrated negative coupling whereas PD demonstrated positive coupling between these networks. We did not observe differences in functional coupling between the L-CEN and either the DMN (*t* = 0.35, *p* = 0.73) or SN (*t* = --1.05, *p* = 0.31). We observed no significant associations between levodopa equivalent dosage (LED) and these measures of functional coupling (all *p* \> 0.46), suggesting that dopamine replacement therapy is not likely to be the explanation of our findings of disrupted inter-network coupling in PD.

3.3. SN--striatal functional coupling decreased in relation to disease severity {#sec3.3}
-------------------------------------------------------------------------------

Striatal coupling with the salience network was related to disease severity as measured by the UPDRS total score (*r* = --0.45, *p* = 0.03) such that more severe disease was associated with diminished functional coupling between the SN and striatum ([Fig. 3](#f0015){ref-type="fig"}). For many of these individuals, more severe disease was associated with reduced positive functional coupling between the striatum and SN, but those individuals with the most severe disease demonstrated anti-correlation in the functional coupling between the SN and striatum. A UPDRS motor sub-score, specifically focusing on severity of the cardinal motor symptoms of PD, was also associated with diminished SN--striatum functional coupling at the level of a trend (*r* = --0.40, *p* = 0.06). Interestingly, SN--striatum functional coupling was significantly related to functional coupling between the SN and CEN (hemisphere averaged) in the PD group (*F* = 0.53, *p* = 0.031) but not in the MC group (*F* = 0.98, *p* = 0.03). We observed no significant association between SN--striatum coupling and LED (*r* = --0.11, *p* = 0.6), suggesting that dopamine replacement is not likely to be related to disrupted SN--striatum coupling. We did not observe statistical differences in the association between disease severity and SN--striatum coupling between LPD and RPD subtypes (*p* \> 0.2).

4. Discussion {#sec4}
=============

We identified disruptions in resting state functional connectivity between large-scale core neurocognitive networks in PD. Specifically, individuals with PD showed connectivity patterns in opposition to what is reported in healthy individuals ([@bb0016]; [@bb0036]; [@bb0049]). We observed an aberrant positive coupling between the R-CEN and DMN in PD, compared to the expected anti-correlation we observed between these two networks in the healthy control group. We also found a reduction in coupling strength between the SN and R-CEN in PD compared to healthy matched adults. The triple network model ([@bb0036]) posits that positive SN--CEN interactions and negative CEN--DMN interactions at rest allow for successful recruitment of the CEN and suppression of the DMN during cognitively challenging task demands. This connectivity among the salience, central executive, and default mode neurocognitive networks is very important to promote efficient cognitive processing in a healthy individual and becomes dysfunctional across a number of brain disorders ([@bb0036]; [@bb0045]). This study demonstrates disrupted intrinsic network interactions among these three neurocognitive networks in PD, providing evidence of disruptions to cortical organization and connectivity in this disease.

In the healthy brain, the SN and CEN are positively coupled, while the DMN and CEN are anti-correlated ([@bb0016]; [@bb0036]; [@bb0049]). The inter-network interactions we observed in our healthy age-matched control population are consistent with these findings in young adults. By contrast, the PD group demonstrated an altered pattern of network interactions. Specifically, in PD we observed *positive* coupling between the R-CEN and DMN, compared to the anti-correlation seen in younger adults ([@bb0016]; [@bb0049]) and our healthy older control participants, possibly reflecting a failure to suppress DMN activity ([@bb0055]) or a failure of modulating top-down signals between the DMN and CEN, as has been previously suggested ([@bb002]). This pattern of dysfunctional DMN large-scale network connectivity is also present in other dopaminergic disorders, such as schizophrenia ([@bb0039]), as well as in other neurodegenerative disorders including Alzheimer\'s disease ([@bb0020]; [@bb0050]).

We also observed reduced functional coupling between the SN and R-CEN in PD compared to the control participants. The insula and dorsal anterior cingulate cortex, key nodes of the salience network ([@bb0045]), are anatomically connected and functionally co-activated with the CEN ([@bb0037]; [@bb0045]). PD pathology proceeds from the striatum to widespread cortical regions, including the insular cortex, soon after manifestation of motor symptomatology ([@bb009]; [@bb0012]; [@bb0024]). Specifically, evidence of alpha-synuclein deposition, a key feature of PD pathology, is detected in the insula by Braak stage 3 ([@bb004]), when clinical motor signs of parkinsonism become apparent ([@bb005]). In the current project, a trend level association was found between the UPDRS motor score and striatal--SN functional coupling, suggesting that disruptions to these networks are relevant to specific motor symptom manifestations of PD. By Braak stage 5, these pathological changes appear to cause alterations of dopamine receptor function and synaptic activity in the insula, contributing to cognitive and autonomic symptoms in PD ([@bb003]; [@bb008]). These pathological changes in the insula likely impact the ability of the SN to effectively recruit and communicate with other neocortical regions such as the dorsolateral prefrontal cortex and posterior parietal cortices that comprise the CEN ([@bb009]; [@bb0049]). The changes we observed in SN--CEN network coupling may reflect increased PD-related pathological burden in the striatum and insula, as is supported by our finding of striatal--SN coupling being significantly related to SN--CEN coupling in PD but not in MC.

Increased PD pathology and dopamine deficiency have been observed as occurring in parallel in the striatum and insula. Recent work has shown that PD patients diagnosed with mild cognitive impairment differed from cognitively normal PD by the presence of greater striatal dopamine depletion related to more D2 receptor loss in the insula ([@bb009]). We observed a breakdown of intrinsic functional coupling between the SN and striatum related to increased disease severity. This observation suggests that PD-related striatal dysfunction may lead to functional disruptions in the communication between the striatum and the insula. We postulate that increased pathology in these regions and further breakdown in communication between them likely continues as PD progresses, contributing to the worsening of cognitive and autonomic symptoms observed in later stages of the disease. Understanding the association between breakdown in functional coupling between these core neurocognitive networks and cognitive performance will be an important focus of future study.

We observed disruptions specific to the right-hemisphere localized central executive network (R-CEN). One possible explanation could be that the L-CEN is localized entirely to the left hemisphere and is implicated strongly with language, verbal memory, and working memory ([@bb0027]). In contrast, the R-CEN reaches across both hemispheres in the parietal lobe and is thought to be involved in more widespread cognitive functions including reasoning, attention, inhibition, and memory ([@bb0027]). A recent study in healthy young adults of hemispheric localization within the CEN and coupling to other networks during the resting state suggests that the left-hemisphere localized CEN is strongly coupled with the DMN and language-related regions in the left-hemisphere, while the right-hemisphere localized CEN is preferentially coupled to the insula and regions of the brain specialized for attention processing ([@bb0056]). This asymmetric specialization of the CEN at rest and stronger preference of DMN to be functionally coupled with L-CEN than R-CEN may set the stage for vulnerability in R-CEN coupling with the DMN in older adults and individuals with neurological disease. Further, preferential coupling between the R-CEN and insula ([@bb0056]) combined with previously described vulnerability of the insula and attention networks in PD ([@bb008]) could further explain why we see aberrant functional coupling specific to the R-CEN but not L-CEN. We do not ascribe this difference in network coupling in the CEN to lateralization of symptoms, as there were no significant subgroup differences in functional coupling with the CEN between RPD and LPD participants. However, these findings of lateralization could also be incidental. Future work examining PD performance across a more extensive neuropsychological assessment battery and with a larger sample size is needed in order to confirm the lateralization of network level findings in the CEN.

There is some evidence from previously published literature that dopaminergic therapy diminishes DMN integrity ([@bb0025]) and is differentially linked to spatial remapping of cortico-striatal connectivity in chronically medicated and drug-naïve patients, such that drug-naïve patients demonstrated striatal hyperconnectivity with cortical regions and PD individuals ON medication demonstrated a general decrease in connectivity strength ([@bb0026]). In the current study, PD participants were evaluated only on peak levels of dopaminergic medications, which limits our ability to address questions related to the effects of dopamine on neurocognitive network interactions. Although our approximation of levodopa equivalent dosage (LED) is not correlated significantly with SN--striatum coupling, we cannot with certainty rule out the possibility that dopamine medication is related in some way to the lower levels of functional coupling we observed between SN and striatum. Despite this limitation, it is worth noting that we did not detect any significant association between any of our functional coupling results and levodopa equivalent dosage (LED). Examining the network connectivity of PD individuals on medication has great utility because most patients experience cognitive dysfunction and disrupted activities in daily living even during peak medication states. Previous work has also shown that dopamine replacement therapy does not ameliorate cognitive disturbances in attentional set-shifting and other aspects of executive functioning ([@bb0031]; [@bb0040]), supported by the neurocognitive networks examined in our study.

We provide evidence in this study of disruptions in the functional coupling among three core neurocognitive networks in participants with PD. Typically, the SN interacts causally with the CEN and the DMN in that increased SN activity correlates with increased activity in the CEN and decreased activity in the DMN. This pattern of interactions is observed both during cognitive tasks and the resting state ([@bb0036]; [@bb0045]; [@bb0049]), reflecting an intrinsic shifting of attention between external and internal processes. Functional activity in the SN and CEN typically increases during cognitive tasks in response to external stimuli ([@bb0013]), whereas DMN activity is suppressed during externally-guided cognitive tasks ([@bb0019]; [@bb0041]), resulting in anti-correlations between the CEN and DMN. Our findings demonstrate aberrant positive CEN coupling with DMN and reduced SN coupling with CEN in PD. Further, our results demonstrate that functional coupling between the striatum and the SN is diminished as disease severity increases. The observed changes in intrinsic functional coupling discussed in this study represent an overarching framework for understanding cortical disruption in PD, similar to the cortical disruption that takes place in the context of other neurodegenerative diseases ([@bb0036]).
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![Three core neurocognitive networks include the default mode network (DMN), salience network (SN), and central executive network separated by left- and right-hemisphere localization (L-CEN and R-CEN). Images are from a previously published set of templates from the BrainMap Database ([@bb0028]).](gr1){#f0005}

![In MC compared to PD, we observed (a) more positive SN coupling with R-CEN (*t* = 2.4, df = 42, *p* = 0.02), and (b) more negative DMN coupling with R-CEN (*t* = --2.1, df = 42, *p* = 0.04).](gr2){#f0010}

![Disease severity as measured by the Unified Parkinson\'s Disease Rating Scale was correlated with functional coupling between the striatum and salience network (SN; *r* = --0.45, *p* = 0.03), such that less positive coupling of these networks was associated with worse disease severity. Each point on the plot represents an individual with PD.](gr3){#f0015}

###### 

Participant characteristics.

  -----------------------------------------------------------------------------------------------------
                                        PD (N = 24)                                       MC (N = 20)
  ------------------------------------- ------------------------------------------------- -------------
  Age (years)                           62.5 ± 6.4                                        65.9 ± 9.4

  Male/female                           12/12                                             9/11

  Education (years)                     17.6 ± 2.2                                        16.6 ± 2.2

  MMSE (out of 30)                      28.6 ± 0.9                                        28.8 ± 0.8

  BDI-II                                5.8 ± 4.4[\*](#ngtbl1.1){ref-type="table-fn"}     2.3 ± 2.9

  BAI                                   5.3 ± 3.7[\*\*](#nstbl1.1){ref-type="table-fn"}   1.5 ± 2.1

  UPDRS total                           27.1 ± 10.8                                       −

  UPDRS motor                           16.1 ± 7.2                                        −

  Levodopa equivalent dosage (mg/day)   368.9 ± 261.9                                     −

  Hoehn and Yahr                        2 (median);\                                      −
                                        1 (min) to 3 (max)                                

  RPD/LPD                               13/11                                             −

  T-PD/AR-PD/G-PD                       12/7/5                                            −
  -----------------------------------------------------------------------------------------------------

MMSE: Mini-Mental State Examination. UPDRS: Unified Parkinson\'s Disease Rating Scale. BDI-II: Beck Depression Inventory, 2nd Edition. BAI: Beck Anxiety Inventory. RPD: Right-side of body symptom at onset. LPD: Left-side of body symptom at onset. T-PD: Tremor at onset. AR-PD: Akinetic--Rigid at onset. G-PD: Gait-instability at onset.

Values presented in the table are means ± standard deviations, unless otherwise noted.

Indicates group differences at a significance level of *p* \< 0.05.

Indicates group differences at a significance level of *p* \< 0.005.

[^1]: Indicates co-last authorship.
